Acadian Asset Management
AGTC

Acadian Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Acadian Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-279,668
Closed -$1.14M – 2406
2020
Q4 		$1.14M Sell
279,668
-80,613
-22% -$396K ﹤0.01% 947
2020
Q3 		$1.75M Sell
360,281
-361,826
-50% -$1.98M 0.01% 707
2020
Q2 		$4M Sell
722,107
-151,430
-17% -$694K 0.02% 527
2020
Q1 		$2.87M Buy
873,537
+168,682
+24% +$889K 0.02% 505
2019
Q4 		$3.18M Buy
704,855
+4,968
+0.7% +$15.7K 0.01% 556
2019
Q3 		$2.91M Buy
+699,887
New +$2.53M 0.01% 584
2019
Q2 		– Sell
-698,053
Closed -$2.93M – 2103
2019
Q1 		$2.93M Buy
698,053
+23,299
+3% +$81.4K 0.01% 589
2018
Q4 		$1.68M Sell
674,754
-12,948
-2% -$75.8K 0.01% 607
2018
Q3 		$5.02M Buy
687,702
+970
+0.1% +$4.25K 0.02% 383
2018
Q2 		$2.54M Sell
686,732
-4,154
-0.6% -$19.2K 0.01% 505
2018
Q1 		$2.66M Buy
690,886
+11,734
+2% +$49.3K 0.01% 534
2017
Q4 		$2.45M Sell
679,152
-13,045
-2% -$49.3K 0.01% 513
2017
Q3 		$2.73M Sell
692,197
-16,061
-2% -$73.8K 0.01% 483
2017
Q2 		$3.61M Sell
708,258
-5,792
-0.8% -$32.5K 0.02% 451
2017
Q1 		$4.93M Sell
714,050
-2,291
-0.3% -$17.9K 0.02% 413
2016
Q4 		$6.7M Buy
716,341
+56,301
+9% +$507K 0.03% 360
2016
Q3 		$6.46M Buy
660,040
+161,215
+32% +$2.17M 0.03% 332
2016
Q2 		$7.05M Buy
498,825
+202,361
+68% +$3.16M 0.04% 307
2016
Q1 		$4.14M Buy
296,464
+207,776
+234% +$3.05M 0.02% 434
2015
Q4 		$1.81M Buy
+88,688
New +$1.37M 0.01% 587
2015
Q2 		– Sell
-773
Closed -$15K – 1537
2015
Q1 		$15K Buy
+773
New +$17.3K ﹤0.01% 1144

Other funds holding AGTC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Acadian Asset Management's AGTC Position: Q1 2021 in Review

Acadian Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2021, closing a stake of 279,668 shares — an estimated $1.14M sold.

Acadian Asset Management first reported a position in AGTC in Q1 2015 and held it in 21 quarters. The position peaked at $7.05M in Q2 2016. 82 funds tracked by Wall St. Rank hold AGTC as of Q1 2021.

  • Acadian Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 279,668 Applied Genetic Technologies Corporation shares in Q1 2021, an estimated $1.14M.
  • Acadian Asset Management first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 21 quarters.
  • Acadian Asset Management's Applied Genetic Technologies Corporation position peaked at $7.05M in Q2 2016.
  • 82 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.